310 related articles for article (PubMed ID: 29921291)
21. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.
Song DY; Herfarth KK; Uhl M; Eble MJ; Pinkawa M; van Triest B; Kalisvaart R; Weber DC; Miralbell R; Deweese TL; Ford EC
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):81-7. PubMed ID: 23414766
[TBL] [Abstract][Full Text] [Related]
22. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.
Kunogi H; Cunha JAM; Chang AJ; Gadzinski AJ; Shinohara K; Hsu IC
Brachytherapy; 2017; 16(6):1113-1118. PubMed ID: 28869143
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
25. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
26. Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study.
Ahmad Khalil D; Wulff J; Jazmati D; Geismar D; Bäumer C; Kramer PH; Steinmeier T; Schleithoff SS; Tschirdewahn S; Hadaschik B; Timmermann B
Curr Oncol; 2023 Jan; 30(1):758-768. PubMed ID: 36661707
[TBL] [Abstract][Full Text] [Related]
27. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
[TBL] [Abstract][Full Text] [Related]
28. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
[TBL] [Abstract][Full Text] [Related]
29. Is there a role for endorectal balloons in prostate radiotherapy? A systematic review.
Smeenk RJ; Teh BS; Butler EB; van Lin EN; Kaanders JH
Radiother Oncol; 2010 Jun; 95(3):277-82. PubMed ID: 20451274
[TBL] [Abstract][Full Text] [Related]
30. Maximizing rectal dose sparing with hydrogel: A retrospective planning study.
Paetkau O; Gagne IM; Pai HH; Lam J; Goulart J; Alexander A
J Appl Clin Med Phys; 2019 Apr; 20(4):91-98. PubMed ID: 30889318
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
[TBL] [Abstract][Full Text] [Related]
32. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
33. Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm.
Ghandour S; Cosinschi A; Mazouni Z; Pachoud M; Matzinger O
Z Med Phys; 2016 Dec; 26(4):362-370. PubMed ID: 27156924
[TBL] [Abstract][Full Text] [Related]
34. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
35. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
[TBL] [Abstract][Full Text] [Related]
36. Plan quality improvement by DVH sharing and planner's experience: Results of a SBRT multicentric planning study on prostate.
Villaggi E; Hernandez V; Fusella M; Moretti E; Russo S; Vaccara EML; Nardiello B; Esposito M; Saez J; Cilla S; Marino C; Stasi M; Mancosu P
Phys Med; 2019 Jun; 62():73-82. PubMed ID: 31153401
[TBL] [Abstract][Full Text] [Related]
37. Volumetric-modulated arc therapy planning using multicriteria optimization for localized prostate cancer.
Ghandour S; Matzinger O; Pachoud M
J Appl Clin Med Phys; 2015 May; 16(3):5410. PubMed ID: 26103500
[TBL] [Abstract][Full Text] [Related]
38. Improvement of prostate treatment by anterior proton fields.
Tang S; Both S; Bentefour H; Paly JJ; Tochner Z; Efstathiou J; Lu HM
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):408-18. PubMed ID: 22133626
[TBL] [Abstract][Full Text] [Related]
39. Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.
Pokhrel D; Sood S; Lominska C; Kumar P; Badkul R; Jiang H; Wang F
J Appl Clin Med Phys; 2015 Sep; 16(5):131–141. PubMed ID: 26699321
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
